| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0014-2999(88)90453-0 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0014299988904530?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:0014299988904530?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 3383997 |
| P2093 | author name string | P. Braquet | |
| C. P. Page | |||
| C. Touvay | |||
| A. J. Coyle | |||
| B. Villain | |||
| S. C. Urwin | |||
| P2860 | cites work | Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man | Q69883641 |
| Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man | Q69893264 | ||
| Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions | Q70068179 | ||
| Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects | Q70168912 | ||
| Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents | Q71527917 | ||
| Release of platelet-activating factor (PAF-acether) and arachidonic acid metabolites from alveolar macrophages | Q71598920 | ||
| From parasites to allergy: a second receptor for IgE | Q85702114 | ||
| Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions | Q93630485 | ||
| Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis | Q33446240 | ||
| Asthma as an axon reflex | Q34382020 | ||
| Effect of platelet agonists on airway reactivity and intrathoracic platelet accumulation | Q35754957 | ||
| The eosinophil and the pathophysiology of asthma | Q39730322 | ||
| Late asthmatic responses: inquiry into mechanisms and significance | Q39817658 | ||
| Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. | Q40920142 | ||
| Mechanism of perennial allergic asthma | Q41534392 | ||
| The effect of platelet activating factor on pulmonary beta-adrenoceptors | Q42566649 | ||
| Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig | Q46814341 | ||
| The platelet in asthma. | Q54465140 | ||
| Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988 | Q58178753 | ||
| Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man | Q69882335 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 51-58 | |
| P577 | publication date | 1988-03-01 | |
| 1988-03-22 | |||
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation | |
| P478 | volume | 148 |
| Q35870833 | Adenosine-induced bronchoconstriction of isolated lung and trachea from sensitized guinea-pigs |
| Q41890589 | Airway hyper- or hyporeactivity to inhaled spasmogens 24 h after ovalbumin challenge of sensitized guinea-pigs |
| Q43577575 | Anaphylactic challenge causes eosinophil accumulation in bronchoalveolar lavage fluid of guinea pigs. Modulation by betamethasone, phenidone, indomethacin, WEB 2086, and a novel antiallergy agent, SCH 37224. |
| Q45079799 | Antigen-induced hyperresponsiveness to methacholine in ventilated, anesthetized guinea pigs |
| Q53652556 | Asthma and anaphylaxis: a relevant model for chronic disease? An historical analysis of directions in asthma research. |
| Q33885948 | Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. |
| Q42476118 | Bronchial hyperresponsiveness and cellular infiltration in the lung of guinea-pigs sensitized and challenged by aerosol |
| Q35824511 | Cationic protein-induced sensory nerve activation: role of substance P in airway hyperresponsiveness and plasma protein extravasation |
| Q35872600 | Characterization of receptors for kinins and neurokinins in the arterial and venous mesenteric vasculatures of the guinea‐pig |
| Q43263960 | Clinical pharmacology and therapeutics |
| Q67478741 | Comparison of the airway hyperreactivity produced by single and multiple antigen exposures in sensitized guinea pigs |
| Q35871499 | Complementary and alternative interventions in asthma, allergy, and immunology |
| Q35609542 | Current status of PAF antagonists |
| Q35585130 | Cytokines, platelet activating factor and eosinophils in asthma |
| Q73049086 | Early and late phase bronchoconstrictions in conscious sensitized guinea-pigs after macro- and microshock inhalation of allergen and associated airway accumulation of leukocytes |
| Q46446377 | Early bronchial hyperresponsiveness following injection of sephadex beads in the guinea pig: involvement of platelet activating factor and thromboxane A2. |
| Q35871608 | Effect of capsaicin on PAF-induced bronchial hyperresponsiveness and pulmonary cell accumulation in the rabbit |
| Q42110638 | Effect of human recombinant interleukin-5 on in vitro responsiveness to PAF of lung from actively sensitized guinea-pigs |
| Q67878207 | Effect of long-term infusion of platelet-activating factor on pulmonary responsiveness and morphology in the guinea-pig |
| Q42126905 | Effect of murine recombinant interleukin-5 on the cell population in guinea-pig airways |
| Q53852379 | Effect of the selective PAF antagonist SM-10661 on an asthmatic model. 1. Effect on passive anaphylactic bronchoconstriction in guinea pigs. |
| Q74792031 | Effect of vagotomy on airway hyperreactivity to endogenously released neurotransmitters at 18-24 h after inhaled antigen |
| Q46696164 | Effects of CIS-19, a novel PAF receptor antagonist, on PAF-induced eosinophil recruitment and enhancement of superoxide anion generation in guinea-pigs |
| Q68078320 | Effects of single and multiple inhalations of platelet-activating factor on airway cell composition and responsiveness in monkeys |
| Q73708186 | Effects of the platelet activating factor antagonists BN 52021 and BN 50730 on antigen-induced bronchial hyperresponsiveness and eosinophil infiltration in lung from sensitized guinea-pigs |
| Q67676528 | Eosinophil accumulation in rats injected with Sephadex particles |
| Q68307640 | Eosinophil infiltration: Effects of H1 antihistamines |
| Q33541182 | Herbal interventions in asthma and allergy |
| Q51681003 | Induction by aerosol allergen of sustained and nonspecific IgE-mediated airway hyperreactivity in the guinea pig |
| Q46640311 | Inhibitory effects of a novel PAF antagonist E6123 on anaphylactic responses in passively and actively sensitized guinea pigs and passively sensitized mice |
| Q41834589 | Interaction of platelet-activating factor with cultured guinea pig tracheal epithelial cells |
| Q36842209 | Interleukin-8 —A Mediator of Inflammatory Lung Disease? |
| Q67893344 | Involvement of platelet-activating factor in zymosan-induced rat pleurisy |
| Q45044329 | Lipid Mediators Contribute to Oxygen-Radical-induced Airway Responses in Sheep |
| Q35871805 | Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung |
| Q44299950 | Multiple antigen challenge produces pulmonary eosinophilia but not pulmonary hyperresponsiveness in actively sensitized guinea pigs |
| Q43653862 | Nedocromil Sodium Inhibits the Increase in Airway Reactivity Induced by Platelet Activating Factor in Humans |
| Q41121327 | PAF and asthma--time for an appraisal? |
| Q37663427 | PAF antagonism as an approach to the treatment of airway hyperreactivity |
| Q43838443 | PAF antagonists in asthma |
| Q57878316 | PAF receptor antagonists in the treatment of asthma |
| Q35888204 | PAF-induced bronchial hyperresponsiveness in the rabbit: contribution of platelets and airway smooth muscle |
| Q46869752 | Pharmacological activity of PF-904 in guinea pig in vivo, and on human bronchus and neutrophils in vitro. |
| Q42113605 | Pharmacological analysis of neutrophil chemotactic factor production by leucocytes and roles of PAF in allergic inflammation in rats |
| Q67807439 | Pharmacological effecs of oral E6123, a novel PAF antagonist, on biological change induced by PAF inhalation in guinea pigs |
| Q36440019 | Platelet activating factor and asthma |
| Q42712073 | Platelet-activating factor (PAF) plays an important role in the immediate asthmatic response in guinea-pig by augmenting the response to histamine |
| Q42084217 | Prevention of non-specific airway hyperreactivity after allergen challenge in guinea-pigs by the PAF receptor antagonist SDZ 64-412. |
| Q72001571 | Relationships among allergen-induced early and late phase airway obstructions, bronchial hyperreactivity, and inflammation in conscious, unrestrained guinea pigs |
| Q37057805 | Role for platelet-activating factor in asthma |
| Q41492450 | Smooth muscle as a direct or indirect target accounting for bronchopulmonary hyperresponsiveness |
| Q37057819 | The contribution of platelet-activating factor to allergen-induced eosinophil infiltration and bronchial hyperresponsiveness |
| Q42109211 | The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin |
| Q46702380 | The effect of platelet activating factor antagonist on ozone-induced airway inflammation and bronchial hyperresponsiveness in guinea pigs |
| Q46957113 | The requirement for platelets in allergen-induced late asthmatic airway obstruction. Eosinophil infiltration and heightened airway responsiveness in allergic rabbits |
| Q41776479 | The role of platelet activating factor in airway inflammation, airway hyperresponsiveness, and pulmonary function in monkeys |
| Q38247605 | The role of platelet activating factor in allergic inflammation |
| Q28768533 | The role of platelet activating factor in allergic respiratory disease |
| Q46308882 | Time course study for airway inflammation and responsiveness by repeated provocation of aeroantigen in guinea pigs |
Search more.